Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2017
Fore Pharma announced the results of its Type 1 Diabetes patients study in a new report ‘Global Type 1 Diabetes Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Type 1 Diabetes epidemiology, Type 1 Diabetes diagnosed patients, and Type 1 Diabetes treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Type 1 Diabetes derived from epidemiological analysis, percentage of patients diagnosed with Type 1 Diabetes, and percentage of patients treated with a therapy.
The study helps executives estimate Type 1 Diabetes market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Type 1 Diabetes prevalence, Type 1 Diabetes diagnosis rate, and Type 1 Diabetes treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.
Key Features of the Report:
- Type 1 Diabetes Patient Flow
- Type 1 Diabetes Prevalence
- Type 1 Diabetes Diagnosed Patients
- Type 1 Diabetes Treated Patients
- 1. Type 1 Diabetes: Disease Definition
- 2. Global Type 1 Diabetes Patient Flow
- 2A. Global Type 1 Diabetes Prevalence
- 2B. Global Type 1 Diabetes Diagnosed Patients
- 2C. Global Type 1 Diabetes Treated Patients
- 3. Type 1 Diabetes Patient Flow in the US
- 3A. Type 1 Diabetes Prevalence in the US
- 3B. Type 1 Diabetes Diagnosed Patients in the US
- 3C. Type 1 Diabetes Treated Patients in the US
- 4. Type 1 Diabetes Patient Flow in Europe
- 4A. Type 1 Diabetes Prevalence in Europe
- 4B. Type 1 Diabetes Diagnosed Patients in Europe
- 4C. Type 1 Diabetes Treated Patients in Europe
- 5. Type 1 Diabetes Patient Flow in Germany
- 5A. Type 1 Diabetes Prevalence in Germany
- 5B. Type 1 Diabetes Diagnosed Patients in Germany
- 5C. Type 1 Diabetes Treated Patients in Germany
- 6. Type 1 Diabetes Patient Flow in France
- 6A. Type 1 Diabetes Prevalence in France
- 6B. Type 1 Diabetes Diagnosed Patients in France
- 6C. Type 1 Diabetes Treated Patients in France
- 7. Type 1 Diabetes Patient Flow in Spain
- 7A. Type 1 Diabetes Prevalence in Spain
- 7B. Type 1 Diabetes Diagnosed Patients in Spain
- 7C. Type 1 Diabetes Treated Patients in Spain
- 8. Type 1 Diabetes Patient Flow in Italy
- 8A. Type 1 Diabetes Prevalence in Italy
- 8B. Type 1 Diabetes Diagnosed Patients in Italy
- 8C. Type 1 Diabetes Treated Patients in Italy
- 9. Type 1 Diabetes Patient Flow in UK
- 9A. Type 1 Diabetes Prevalence in UK
- 9B. Type 1 Diabetes Diagnosed Patients in UK
- 9C. Type 1 Diabetes Treated Patients in UK
- 10. Type 1 Diabetes Patient Flow in Japan
- 10A. Type 1 Diabetes Prevalence in Japan
- 10B. Type 1 Diabetes Diagnosed Patients in Japan
- 10C. Type 1 Diabetes Treated Patients in Japan
- 11. Research Methodology
- List of Tables
- Table 1: Global Type 1 Diabetes Patient Flow, 2016
- Table 2: Global Type 1 Diabetes Patient Flow Forecast, 2016 - 2025
- Table 3: Type 1 Diabetes Patient Flow in the US, 2016
- Table 4: Type 1 Diabetes Patient Flow Forecast in the US, 2016 - 2025
- Table 5: Type 1 Diabetes Patient Flow in Europe, 2016
- Table 6: Type 1 Diabetes Patient Flow Forecast in Europe, 2016 - 2025
- Table 7: Type 1 Diabetes Patient Flow in Germany, 2016
- Table 8: Type 1 Diabetes Patient Flow Forecast in Germany, 2016 - 2025
- Table 9: Type 1 Diabetes Patient Flow in France, 2016
- Table 10: Type 1 Diabetes Patient Flow Forecast in France, 2016 - 2025
- Table 11: Type 1 Diabetes Patient Flow in Spain, 2016
- Table 12: Type 1 Diabetes Patient Flow Forecast in Spain, 2016 - 2025
- Table 13: Type 1 Diabetes Patient Flow in Italy, 2016
- Table 14: Type 1 Diabetes Patient Flow Forecast in Italy, 2016 - 2025
- Table 15: Type 1 Diabetes Patient Flow in UK, 2016
- Table 16: Type 1 Diabetes Patient Flow Forecast in UK, 2016 - 2025
- Table 17: Type 1 Diabetes Patient Flow in Japan, 2016
- Table 18: Type 1 Diabetes Patient Flow Forecast in Japan, 2016 - 2025
- List of Figures
- Figure 1: Global Type 1 Diabetes Patient Flow, 2016
- Figure 2: Global Type 1 Diabetes Patient Flow Forecast, 2016 - 2025
- Figure 3: Type 1 Diabetes Patient Flow in the US, 2016
- Figure 4: Type 1 Diabetes Patient Flow Forecast in the US, 2016 - 2025
- Figure 5: Type 1 Diabetes Patient Flow in Europe, 2016
- Figure 6: Type 1 Diabetes Patient Flow Forecast in Europe, 2016 - 2025
- Figure 7: Type 1 Diabetes Patient Flow in Germany, 2016
- Figure 8: Type 1 Diabetes Patient Flow Forecast in Germany, 2016 - 2025
- Figure 9: Type 1 Diabetes Patient Flow in France, 2016
- Figure 10: Type 1 Diabetes Patient Flow Forecast in France, 2016 - 2025
- Figure 11: Type 1 Diabetes Patient Flow in Spain, 2016
- Figure 12: Type 1 Diabetes Patient Flow Forecast in Spain, 2016 - 2025
- Figure 13: Type 1 Diabetes Patient Flow in Italy, 2016
- Figure 14: Type 1 Diabetes Patient Flow Forecast in Italy, 2016 - 2025
- Figure 15: Type 1 Diabetes Patient Flow in UK, 2016
- Figure 16: Type 1 Diabetes Patient Flow Forecast in UK, 2016 - 2025
- Figure 17: Type 1 Diabetes Patient Flow in Japan, 2016
- Figure 18: Type 1 Diabetes Patient Flow Forecast in Japan, 2016 - 2025
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBookOther tasks
